These are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Thursday.
Activision Blizzard Inc. (NASDAQ: ATVI) raised to Overweight at Piper Jaffray.
Arena Pharmaceuticals Inc. (NASDAQ: ARNA) started as Underperform at Credit Suisse.
Barclays PLC (NYSE: BCS) cut to Neutral at Credit Suisse.
CIT Group Inc. (NYSE: CIT) started as Perform at Oppenheimer.
Cliffs Natural Resources Inc. (NYSE: CLF) cut to Neutral at UBS.
Express Scripts Inc. (NASDAQ: ESRX) maintained Hold but raised 2012/2013 earnings estimates at Argus.
Nokia Corp. (NYSE: NOK) cut to Sell at Deutsche Bank; Cut to Sell at Soc-Gen; Cut to Sell at S&P Equity Research.
Novo Nordisk A/S (NYSE: NVO) raised to Neutral at Nomura.
Orexigen Therapeutics Inc. (NASDAQ: OREX) started as Outperform at Credit Suisse.
Pep Boys – Manny, Moe & Jack (NYSE: PBY) started as Neutral at Credit Suisse.
Randgold Resources Ltd. (NASDAQ: GOLD) raised to Overweight at JPMorgan, but shares were cut to Neutral at Nomura just the day before.
Stanley Black & Decker Inc. (NYSE: SWK) raised to Overweight at Morgan Stanley.
SunTrust Banks Inc. (NYSE: STI) raised to Overweight at JPMorgan.
Vistaprint N.V. (NASDAQ: VPRT) raised to Sell from Strong Sell at S&P Capital IQ … Is that just “less of a sell but still a sell” rating?
Credit Suisse gave a model portfolio trade alert called “go long” on KeyCorp (NYSE: KEY). It said, “We look for 3Q12 and 4Q12 EPS to beat market expectations, and believe investors will increase EPS estimates for ’13/’14 in 2H12. We believe this will be driven by core efficiency ratio improvement in 2H12.”
JON C. OGG